Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Preclinical results reported for Novartis' PDE IV inhibitor

Dec. 1, 1997

New antiasthma compound reported at Japanese congress

Dec. 1, 1997

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Bronchodilating mechanism of PDE IV inhibitors investigated using CP-80633

Nov. 27, 1997

Ono's elastase inhibitor poised to enter phase I in Europe

Nov. 27, 1997

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...